Maze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.

Chief Medical Officer Harold Bernstein sold 15,000 shares for approximately $442,000 (~$29.46 per share) on April 1, 2026. The report is a straightforward insider sale by a senior medical executive with no accompanying operational or guidance news; the transaction appears routine and unlikely to affect the company's fundamentals materially.

Analysis

Chief Medical Officer Harold Bernstein sold 15,000 shares for approximately $442,000 (~$29.46 per share) on April 1, 2026. The report is a straightforward insider sale by a senior medical executive with no accompanying operational or guidance news; the transaction appears routine and unlikely to affect the company's fundamentals materially.